Speed is key in bringing new drugs to patients. Speed in clearing regulatory hurdles, gearing up to product launch, gaining market share—a setback at any point in a drug’s journey deprives patients of novel treatment, inflates costs and truncates patent protection. Fortunately, changing the approach to finding, enrolling and keeping study patients can shorten timelines, improve data quality and heighten a study’s odds for success.
Author: Kurt Mussina, MBA
Fresenius Medical Care Newsroom | August 14, 2018